Bitter, Eliza E.
Townsend, Michelle H.
Erickson, Rachel
Allen, Carolyn
O’Neill, Kim L. https://orcid.org/0000-0002-8747-6217
Article History
Received: 23 April 2020
Accepted: 9 November 2020
First Online: 27 November 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors wish to point out that they are associated with Thunder Biotech, an immunotherapeutic company involved in the development of CAR T-Cell technology. Some of the authors have financial interests and hold shares in this company (E.B, M.T., K.O.).